Mark Rundell

Mark Rundell serves as the Senior Staff Innovation Danaher Business System Leader at Beckman Coulter Diagnostics, where responsibilities include leading innovation processes, developing biomarker scouting procedures, and managing project initiatives that enhance commercialization strategies. Rundell has extensive experience as an IVDR Program Manager, overseeing compliance for Clinical Chemistry and Immunoassay products, and previously held roles as an applications scientist and systems scientist focused on diagnostic tool validation. Prior experience includes an Innovation Manager position at DH Diagnostics LLC and a Postdoctoral Associate role at Weill Cornell Medical College, complemented by advanced research in genetics and toxicology during academic pursuits at the University of Illinois Urbana-Champaign, where Rundell earned a Ph.D. in Genetics.